News for 'Development Control Regulations'

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

Rediff.com14 Jun 2021

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini Das

Sebi diktat on splitting chairman, MD/CEO roles

Sebi diktat on splitting chairman, MD/CEO roles

Rediff.com6 Apr 2021

Capital markets regulator Sebi on Tuesday asked listed companies to work towards splitting the roles of chairman and managing director before the April 2022 deadline, as the new directive is not aimed at weakening the position of promoters. Listed entities were initially required to separate the roles of chairperson and MD/CEO from April 1, 2020 onwards. However, based on industry representations, an additional time period of two years was given for compliance. The regulation will now be applicable to the top 500 listed entities by market capitalisation, with effect from April 1, 2022.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

DGCA plans to bring airline staff under breathalyser

DGCA plans to bring airline staff under breathalyser

Rediff.com17 Aug 2019

The regulator is now planning to bring in other workers in the aviation ecosystem under the purview of the breath-analyser test. It will include air traffic control officers (ATCOs), ground-handling personnel, flight despatchers, aerodrome operation personnel and engineers.

Government crackdown on misuse of antibiotics

Government crackdown on misuse of antibiotics

Rediff.com25 Jan 2017

Sale of antibiotics is under the scanner. Government to go tough on misuse of these drugs.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Govt nod for SBI-led group to take over Yes Bank?

Govt nod for SBI-led group to take over Yes Bank?

Rediff.com5 Mar 2020

The government has given a go-ahead to State Bank of India and other financial institutions to take over capital-starved Yes Bank, and an announcement is likely to be made soon, highly places sources said on Thursday. The board of SBI, the country's largest lender, is meeting in Mumbai on Thursday, but it could not be immediately ascertained whether the takeover of Yes Bank is on the agenda. Yes Bank, which is grappling with bad loans, is looking to raise fresh capital but the plans are facing uncertainties.

Jhunjhunwala's Akasa Airlines in talks with Boeing for up to 100 Max jets

Jhunjhunwala's Akasa Airlines in talks with Boeing for up to 100 Max jets

Rediff.com17 Aug 2021

Rakesh Jhunjhunwala-backed new airline Akasa is in talks with US aerospace company Boeing for buying up to 100 737 Max aircraft. Former Jet Airways CEO Vinay Dube and his family members are promoters while ex-IndiGo president Aditya Ghosh is a board member of the airline. The airline is in negotiation with Boeing and has reached out to the government to recertify the aircraft which has been grounded since 2018 after two crashes killing 349 persons, according to sources in the know.

WELLNESS GURU: 10 Good Things I Can Feed My Family

WELLNESS GURU: 10 Good Things I Can Feed My Family

Rediff.com29 Aug 2022

Wellness expert Roopashree Sharma answers your health queries.

Centre asks UP, Bihar to prevent dumping of bodies in Ganga

Centre asks UP, Bihar to prevent dumping of bodies in Ganga

Rediff.com16 May 2021

The Centre directed Uttar Pradesh and Bihar on Sunday to prevent dumping of dead bodies in the Ganga and its tributaries, and focus on their safe disposal and a dignified cremation after corpses were seen floating in these rivers following a spurt in the number of coronavirus cases.

Rising fuel prices may hit BPCL's divestment plan

Rising fuel prices may hit BPCL's divestment plan

Rediff.com26 Oct 2021

The divestment of Bharat Petroleum Corporation (BPCL) may hit a fuel price hurdle, according to officials dealing with the matter. They pointed out that the inconspicuous administered price regime could hamper the prospects for potential buyers of BPCL. A senior oil ministry official said public-sector oil-marketing companies (OMCs) take a hit when they sell petrol, diesel, and liquefied petroleum gas (LPG), three of the most popular petroleum products in the country.

FAQ: Is it safe to take antibody cocktail for Covid-19?

FAQ: Is it safe to take antibody cocktail for Covid-19?

Rediff.com10 Jun 2021

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

'Profiting from Pain': Covid created new billionaire every 30 hrs

'Profiting from Pain': Covid created new billionaire every 30 hrs

Rediff.com23 May 2022

Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.

Data privacy: Tension between big technology firms and govt boils over

Data privacy: Tension between big technology firms and govt boils over

Rediff.com22 Mar 2021

There is a perception getting built inside the government that big technology companies -- a common term used for firms like Facebook, Google, Twitter, Amazon and the like - are becoming very powerful and present multiple threats to entire nations and their citizens today. The digital ecosystem is replete with CSAM (child sexual abuse material), fake news, drug trade, radicalisation, trolling among other social vices. Given the network effect that these platforms have, it is important to ensure that these platforms are not misused.

Arunachal Pradesh has ALWAYS been part of India

Arunachal Pradesh has ALWAYS been part of India

Rediff.com15 Dec 2021

China has long coveted Arunachal Pradesh, which it calls Southern Tibet. But, as Venkataraghavan Subha Srinivasan explains, in 1947, the present state of Arunachal Pradesh constituted the North East Frontier Tract of Assam. When India adopted its Constitution on 26 January 1950, NEFT became 'a separate politico-administrative entity' although it was constitutionally still a part of Assam. Its administration was brought directly under the President of India with the Governor of Assam acting as his agent. A revealing excerpt from his book The Origin Story of India's States.

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Rediff.com19 Aug 2020

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.

What homebuyers MUST know

What homebuyers MUST know

Rediff.com21 Jun 2018

Tinesh Bhasin explores the limitations of rights granted to homebuyers under the Insolvency and Bankruptcy Code.

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Google new features promise better privacy tools

Google new features promise better privacy tools

Rediff.com8 May 2019

The company said this new approach allows developers to train artificial intelligence models without the user data leaving the device, while allowing it to do more with less data.

Lok Sabha okays Bill to ban financing of weapons of mass destruction

Lok Sabha okays Bill to ban financing of weapons of mass destruction

Rediff.com7 Apr 2022

External Affairs Minister S Jaishankar said the passage of the amendment will strengthen India's national security and its global position.

'Real money in the market is made by remaining invested for long'

'Real money in the market is made by remaining invested for long'

Rediff.com9 Aug 2021

'Waiting for a market correction and optimising entry time in the markets will be akin to missing the woods for the trees.'

Why India needs an independent media

Why India needs an independent media

Rediff.com10 Apr 2021

The government is attempting everything it can to make sure that this does not happen, observes Aakar Patel.

Serum Inst gets DGCI notice over continuation of vaccine trial

Serum Inst gets DGCI notice over continuation of vaccine trial

Rediff.com9 Sep 2020

The show-cause notice was issued following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold after a United Kingdom participant had an adverse reaction to it.

PMC Bank chairman's HDIL link runs really deep

PMC Bank chairman's HDIL link runs really deep

Rediff.com4 Oct 2019

While Waryam Singh was a non-executive director at HDIL, he is listed as one of the promoters of the company and had relations, including shareholding, with several other entities controlled by the Wadhawans, the HDIL founders.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

FinMin-RBI differences come to the fore again

FinMin-RBI differences come to the fore again

Rediff.com31 Oct 2018

The Financial Stability and Development Council meeting on Tuesday started with an air of tension in the room. An official present described the participants' body language as "tetchy". However, once presentations and discussions begun, the mood considerably eased.

DGCA error forced Pak F-16s to intercept SpiceJet flight

DGCA error forced Pak F-16s to intercept SpiceJet flight

Rediff.com19 Oct 2019

The DGCA official who wrongly assigned the code of Antonov AN-32 -- an aircraft used by the IAF -- to the SpiceJet aircraft has been suspended, report Arindam Majumder and Aneesh Phadnis.

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Rediff.com11 Aug 2021

India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.

Covid vaccine to cost Rs 290 to govt; Rs 585 in pvt mkt: Serum

Covid vaccine to cost Rs 290 to govt; Rs 585 in pvt mkt: Serum

Rediff.com4 Jan 2021

Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

How the RBI's new home finance rules affect you

How the RBI's new home finance rules affect you

Rediff.com6 Jul 2020

'Real estate loans are given in the garb of retail loans, sourcing money cheap from the NHB refinance window.' 'This loophole is being plugged,' notes Tamal Bandyopadhyay.

ASK KOMAL: How do I reduce my belly?

ASK KOMAL: How do I reduce my belly?

Rediff.com6 May 2021

Dietician Komal Jethmalani provides the right answer.

Amazon accuses Future of insider trading

Amazon accuses Future of insider trading

Rediff.com11 Nov 2020

Amazon has shot off yet another letter to market regulator Sebi, accusing Future Retail of insider trading and called for an investigation as the US online retailer looks to ratchet up pressure against the Future-RIL deal. Future Group, however, vehemently denied the charges, saying these allegations were "Amazon's ill-motivated attempts to throw everything at the situation to stultify the transaction."

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

AIIMS doctors call off strike after talks with Vardhan

AIIMS doctors call off strike after talks with Vardhan

Rediff.com4 Aug 2019

Doctors are demanding certain amendments in the bill. According to them, if not amended, the bill will lead to deterioration of medical education and degradation of healthcare services.

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Rediff.com1 Jul 2021

Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture 10-12 crore doses annually.

'Our partnership with BharatPe is firm and good'

'Our partnership with BharatPe is firm and good'

Rediff.com8 Feb 2022

'Banking is a business of trust.'

A case for raising defence FDI to 100%

A case for raising defence FDI to 100%

Rediff.com14 Nov 2020

Access to India's defence market must be made conditional -- available only to those who are ready to make a long-term commitment in India, argues Ajai Shukla.